Stephen Morrissey

Associate

  • Stephen Morrissey
  • Phone: +1 215 979 1267
    Fax: +1 215 689 2494

    Import to Address Book

  • Duane Morris LLP
    30 South 17th Street
    Philadelphia, PA 19103-4196
    USA

Stephen P. Morrissey practices in the area of corporate law. Mr. Morrissey has experience with mergers and acquisitions, private equity, securities law and corporate compliance.

Mr. Morrissey is a 2016 graduate of the University of Pennsylvania Law School, where he was associate editor of Vol. 17 of the University of Pennsylvania Journal of Constitutional Law and Vol. 9 of the University of Pennsylvania East Asia Law Review, and a summa cum laude graduate of the University of Pennsylvania.

Areas of Practice

  • Corporate Law

Representative Matters

  • Represented UL Holdings, the owner of UrbnLeaf, a cannabis business based in San Diego, California, in its offering of Series A Preferred Stock to investors, as well as the issuance of certain Convertible Promissory Notes.

  • Represented Catalent Biologics’ (NYSE: CTLT) Paragon Gene Therapy unit, the leading viral vector development and manufacturing partner for gene therapies, in its acquisition of manufacturing equipment and related assets from, and strategic partnership with, Novavax, Inc. (Nasdaq: NVAX), a late-stage biotech company developing next-generation vaccines for infectious diseases; the transaction expands Paragon’s gene therapy business and offers Novavax a cost-effective solution to its manufacturing needs.

Admissions

  • Pennsylvania
  • Delaware

Education

  • University of Pennsylvania Carey Law School, J.D., 2016
    ◦ Associate Editor, University of Pennsylvania Journal of Constitutional Law, Vol. 17
    ◦ Associate Editor, University of Pennsylvania East Asia Law Review, Vol. 9
  • University of Pennsylvania, B.A., summa cum laude, 2012

Experience

  • Duane Morris LLP
    - Associate, 2018-present

  • Skadden, Arps, Slate, Meagher & Flom
    - Associate, 2016-2018

Selected Publications